These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4976438)

  • 41. Ethionamide-induced hypothyroidism.
    Dutta BS; Hassan G; Waseem Q; Saheer S; Singh A
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):141. PubMed ID: 22236862
    [No Abstract]   [Full Text] [Related]  

  • 42. Coma from long-term overingestion of isoniazid.
    Salkind AR; Hewitt CC
    Arch Intern Med; 1997 Nov; 157(21):2518-20. PubMed ID: 9385305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Functional state of the liver in patients with pulmonary tuberculosis during treatment with chemopreparations of the 2d series].
    Vasilik GV
    Probl Tuberk; 1968; 46(8):43-7. PubMed ID: 5709113
    [No Abstract]   [Full Text] [Related]  

  • 44. [Experiences with antitubercular agents of the second line].
    Zierski M
    Wien Med Wochenschr; 1966 Oct; 116(40):824-7. PubMed ID: 5927179
    [No Abstract]   [Full Text] [Related]  

  • 45. [Hepato-digestive tolerance to prothionamide].
    Lesorbre R; Delacoux E; Frey N; Wilmotte F; Legrand M
    Ann Biol Clin (Paris); 1968; 26(5):681-8. PubMed ID: 5681857
    [No Abstract]   [Full Text] [Related]  

  • 46. [Reflex algodystrophic syndrome of the knee after meniscus surgery].
    Navrátil J
    Fysiatr Revmatol Vestn; 1982 Dec; 60(6):320-5. PubMed ID: 6186591
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of isoniazid on pyridoxine (vitamin B6) metabolism in children. Experimental study].
    Rajtar-Leontiew Z
    Ann Pediatr (Paris); 1970 Feb; 17(2):150-63. PubMed ID: 5513157
    [No Abstract]   [Full Text] [Related]  

  • 48. Electrophysiological evidence of peripheral nerve damage in patients treated with isoniazid.
    Bahemuka M; Kioy PM; Wanjama M; Wainaina CM
    East Afr Med J; 1982 Dec; 59(12):798-802. PubMed ID: 6191942
    [No Abstract]   [Full Text] [Related]  

  • 49. [Comparison of combination therapy of Capreomycin, ethionamide and cycloserin with that of kanamycin, ethionamide and cycloserin for the retreatment of pulmonary tuberculosis].
    Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
    Saishin Igaku; 1970 Jul; 25(7):1546-55. PubMed ID: 5451178
    [No Abstract]   [Full Text] [Related]  

  • 50. [Reflex sympathetic dystrophy of the upper limb secondary to barbiturate treatment. A report of 3 cases and a review of the literature].
    Lucantoni C; Grottoli S; Bianchini LM; Gaetti R
    Recenti Prog Med; 1994 Jun; 85(6):328-32. PubMed ID: 8047681
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [New findings concerning the biochemical mechanisms of the tuberculous process and the correction of biochemical abnormalities using etiopathogenetic preparations].
    Maliuk VI
    Probl Tuberk; 1984 Nov; (11):61-4. PubMed ID: 6395132
    [No Abstract]   [Full Text] [Related]  

  • 52. Serum levels, urinary excretion, and side-effects of cycloserine in the presence of isoniazid and p-aminosalicylic acid.
    Mattila MJ; Nieminen E; Tiitinen H
    Scand J Respir Dis; 1969; 50(4):291-300. PubMed ID: 5380786
    [No Abstract]   [Full Text] [Related]  

  • 53. [Algo-neuro-dystrophy due to barbiturates: A particular case of medicamentous rheumatism].
    Saudan Y; Chavannes F; Schelling JL; Pagani JP; Chevalley G
    Schweiz Rundsch Med Prax; 1971 Oct; 60(40):1330-3. PubMed ID: 5098929
    [No Abstract]   [Full Text] [Related]  

  • 54. [Results of treatment of chronic destructive pulmonary tuberculosis with reserve tuberculostatic preparations including some new preparations].
    Rabukhin AE; Alekseeva VM; Ivanova ES; Kubyshkina VF; Kliuchareva EA
    Probl Tuberk; 1970; 48(8):18-22. PubMed ID: 5496733
    [No Abstract]   [Full Text] [Related]  

  • 55. [Prolongation of the Q-T interval while taking isoniazid].
    Makarov LM; Chuprova SN; Garipov RSh; Sorokina EV; Poliakova EB; Kalinin LA
    Ter Arkh; 2003; 75(12):54-8. PubMed ID: 14959472
    [No Abstract]   [Full Text] [Related]  

  • 56. [Trevintix in the treatment of tuberculous patients (tolerance evaluation)].
    Pregowski W; Zagórecka A
    Gruzlica; 1968; 37(1):39-42. PubMed ID: 5720036
    [No Abstract]   [Full Text] [Related]  

  • 57. Sympathetic dystrophy associated with sirolimus therapy.
    Molina MG; Diekmann F; Burgos D; Cabello M; Lopez V; Oppenheimer F; Navarro A; Campistol J
    Transplantation; 2008 Jan; 85(2):290-2. PubMed ID: 18212635
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Evaluation of the therapeutic effects of secondary antitubercular agents].
    Watanabe S; Nosaki M; Iwasaki M; Hamano S; Furuya Y
    Iryo; 1966 Mar; 20(3):251-6. PubMed ID: 5965119
    [No Abstract]   [Full Text] [Related]  

  • 59. [The effect of antibacterial agents on the function of the adrenal cortex in patients with siderosilicotuberculosis].
    Koval'chuk AA; Malov VV
    Vrach Delo; 1966 Apr; 4():100-2. PubMed ID: 6011372
    [No Abstract]   [Full Text] [Related]  

  • 60. Risk factors for development of tuberculosis after isoniazid chemoprophylaxis in human immunodeficiency virus-infected patients.
    Casado JL; Moreno S; Fortún J; Antela A; Quereda C; Navas E; Moreno A; Dronda F
    Clin Infect Dis; 2002 Feb; 34(3):386-9. PubMed ID: 11753825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.